Collegium completes Ironshore acquisition (September 2024)
Collegium Pharmaceutical completed the acquisition of Ironshore Pharmaceuticals / Therapeutics on 3 September 2024 (announced July 2024). Announced cash consideration was approximately $525M.
Source: https://ir.collegiumpharma.com/news-releases/news-release-details/collegium-completes-acquisition-ironshore-therapeutics